CeriBell (CBLL) Competitors $17.50 +0.36 (+2.10%) Closing price 04:00 PM EasternExtended Trading$17.52 +0.02 (+0.14%) As of 07:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock CBLL vs. LIVN, WRBY, NVCR, LMAT, CNMD, ENOV, EYE, TNDM, CDRE, and LQDAShould you be buying CeriBell stock or one of its competitors? The main competitors of CeriBell include LivaNova (LIVN), Warby Parker (WRBY), NovoCure (NVCR), LeMaitre Vascular (LMAT), CONMED (CNMD), Enovis (ENOV), National Vision (EYE), Tandem Diabetes Care (TNDM), Cadre (CDRE), and Liquidia (LQDA). These companies are all part of the "medical equipment" industry. CeriBell vs. LivaNova Warby Parker NovoCure LeMaitre Vascular CONMED Enovis National Vision Tandem Diabetes Care Cadre Liquidia LivaNova (NASDAQ:LIVN) and CeriBell (NASDAQ:CBLL) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation, institutional ownership and community ranking. Is LIVN or CBLL more profitable? LivaNova has a net margin of 1.91% compared to CeriBell's net margin of 0.00%. LivaNova's return on equity of 13.81% beat CeriBell's return on equity.Company Net Margins Return on Equity Return on Assets LivaNova1.91% 13.81% 7.07% CeriBell N/A N/A N/A Does the MarketBeat Community favor LIVN or CBLL? LivaNova received 399 more outperform votes than CeriBell when rated by MarketBeat users. However, 100.00% of users gave CeriBell an outperform vote while only 69.80% of users gave LivaNova an outperform vote. CompanyUnderperformOutperformLivaNovaOutperform Votes40969.80% Underperform Votes17730.20% CeriBellOutperform Votes10100.00% Underperform VotesNo Votes Which has higher earnings and valuation, LIVN or CBLL? LivaNova has higher revenue and earnings than CeriBell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLivaNova$1.28B1.92$17.55M-$4.09-10.96CeriBell$71.54M8.74N/AN/AN/A Does the media favor LIVN or CBLL? In the previous week, LivaNova had 4 more articles in the media than CeriBell. MarketBeat recorded 4 mentions for LivaNova and 0 mentions for CeriBell. LivaNova's average media sentiment score of 1.12 beat CeriBell's score of 0.00 indicating that LivaNova is being referred to more favorably in the media. Company Overall Sentiment LivaNova Positive CeriBell Neutral Do analysts recommend LIVN or CBLL? LivaNova currently has a consensus target price of $59.29, suggesting a potential upside of 32.30%. CeriBell has a consensus target price of $32.50, suggesting a potential upside of 87.97%. Given CeriBell's higher probable upside, analysts clearly believe CeriBell is more favorable than LivaNova.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LivaNova 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00CeriBell 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders believe in LIVN or CBLL? 97.6% of LivaNova shares are held by institutional investors. 0.3% of LivaNova shares are held by company insiders. Comparatively, 20.1% of CeriBell shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryLivaNova beats CeriBell on 9 of the 14 factors compared between the two stocks. Get CeriBell News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CBLL vs. The Competition Export to ExcelMetricCeriBellElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$624.91M$3.32B$5.49B$8.59BDividend YieldN/A1.80%5.26%4.19%P/E RatioN/A18.0627.2320.00Price / Sales8.74185.97413.04135.15Price / CashN/A44.0938.2534.64Price / BookN/A3.856.954.65Net IncomeN/A$94.03M$3.23B$247.87M7 Day Performance1.59%0.58%3.13%2.25%1 Month Performance6.86%12.44%8.76%9.13%1 Year PerformanceN/A-7.86%27.88%10.90% CeriBell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CBLLCeriBell1.873 of 5 stars$17.50+2.1%$32.50+85.7%N/A$632.50M$71.54M0.00N/ALIVNLivaNova2.8759 of 5 stars$43.41+0.4%$59.29+36.6%-26.5%$2.37B$1.28B103.362,900WRBYWarby Parker1.9928 of 5 stars$21.49+1.5%$22.88+6.4%+19.4%$2.25B$795.09M-79.603,030Positive NewsNVCRNovoCure3.5856 of 5 stars$17.04-10.8%$32.83+92.7%-26.7%$1.90B$621.71M-12.171,320Positive NewsAnalyst RevisionGap DownHigh Trading VolumeLMATLeMaitre Vascular2.4365 of 5 stars$80.40-2.2%$97.83+21.7%+6.6%$1.82B$226.26M43.93490Positive NewsCNMDCONMED4.3902 of 5 stars$55.32-2.5%$62.20+12.4%-27.2%$1.71B$1.32B13.054,100Positive NewsENOVEnovis2.5329 of 5 stars$29.62-5.4%$58.00+95.8%-32.9%$1.69B$2.15B-13.536,800High Trading VolumeEYENational Vision3.3789 of 5 stars$21.19+7.0%$17.75-16.2%+36.4%$1.68B$1.85B-105.9414,000Positive NewsShort Interest ↓Gap DownHigh Trading VolumeTNDMTandem Diabetes Care4.3053 of 5 stars$20.22+2.0%$35.86+77.3%-60.6%$1.35B$982.95M-10.482,600Positive NewsCDRECadre2.2383 of 5 stars$32.97+0.6%$37.00+12.2%+7.6%$1.34B$559.81M39.722,240LQDALiquidia3.6381 of 5 stars$16.87+13.1%$26.67+58.1%+23.4%$1.28B$14.14M-10.3550High Trading Volume Related Companies and Tools Related Companies LivaNova Alternatives Warby Parker Alternatives NovoCure Alternatives LeMaitre Vascular Alternatives CONMED Alternatives Enovis Alternatives National Vision Alternatives Tandem Diabetes Care Alternatives Cadre Alternatives Liquidia Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CBLL) was last updated on 6/5/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredJunior Explorer Taps Into TSMC’s $165 Billion Chip CorridorThe chip war is moving underground. As the U.S. ramps up semiconductor production to outpace China, an unex...Capital Trends | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredThe “black glass” breakthrough behind AI’s next leapAI is advancing fast… But there’s one problem almost no one’s talking about. Power.True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CeriBell Please log in to your account or sign up in order to add this asset to your watchlist. Share CeriBell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CBLL Stock Free CBLL Stock Alerts